Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

PHASE2UnknownINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 25, 2018

Primary Completion Date

July 7, 2020

Study Completion Date

July 7, 2020

Conditions
Cervical CancerCervical Cancer MetastaticCervical Cancer Recurrent
Interventions
BIOLOGICAL

BCD-100

Anti-PD-1 monoclonal antibody, IV infusion

BIOLOGICAL

Bevacizumab

IV infusion

DRUG

Paclitaxel

IV infusion

DRUG

Cisplatin (or carboplatin)

IV infusion

Trial Locations (24)

111123

RECRUITING

Moscow Clinical Scientific and Practical Center named A.S. Loginova, Moscow

115478

RECRUITING

N.N. Blokhin National Medical Research Center of Oncology (2), Moscow

RECRUITING

N.N. Blokhin National Medical Research Center of Oncology, Moscow

123056

RECRUITING

"JSC Medsi Group of Companies", Moscow

143423

RECRUITING

Moscow City Oncology Hospital No. 62, Moscow

150054

RECRUITING

Regional Clinical Oncology Hospital, Yaroslavl

163045

RECRUITING

Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk

183047

RECRUITING

Murmansk Regional Clinical Hospital named after P.A. Bayandina, Murmansk

190013

RECRUITING

"JSC Modern Medical Technologies", Saint Petersburg

197082

RECRUITING

"LLC AB Medical Group", Saint Petersburg

197758

RECRUITING

N.N. Petrov National Medical Research Center of Oncology (2), Saint Petersburg

RECRUITING

N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg

RECRUITING

Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), Saint Petersburg

249036

RECRUITING

National Medical Radiology Research Center, Obninsk

350040

RECRUITING

Clinical Oncologic Dispensary No. 1, Krasnodar

355047

RECRUITING

Stavropol Regional Clinical Oncology Center, Stavropol

357500

RECRUITING

"LLC New Clinic", Pyatigorsk

420029

RECRUITING

Republican Clinical Oncology Cente, Kazan'

430005

RECRUITING

Republican Oncology Center, Saransk

454087

RECRUITING

Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk

620036

RECRUITING

Sverdlovsk Regional Oncology Center, Yekaterinburg

644013

RECRUITING

Clinical Oncology Dispensary, Omsk

656045

RECRUITING

City Hospital No. 5, Barnaul

660133

RECRUITING

Krasnoyarsk Regional Clinical Oncological Dispensary named after A.I. Kryzhanovsky, Krasnoyarsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biocad

INDUSTRY

NCT03912402 - Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) | Biotech Hunter | Biotech Hunter